Half-year report · Q2
3762.TEDINET S100URH7
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥30.8bn | 2024-04-01 → 2024-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥53.3bn | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥24.6bn | 2023-04-01 → 2023-09-30 | Cons. | Revenue IFRS |
| Operating income | ¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥2.8bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥5.9bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥2.3bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥1.7bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥3.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥1.4bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥4.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥1.6bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss IFRS |
| Total assets | ¥94.3bn | at 2024-09-30 | Cons. | Assets IFRS |
| Total assets | ¥85.8bn | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥72.5bn | at 2023-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥66.1bn | at 2024-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥58.7bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥28.1bn | at 2024-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥27.0bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥25.0bn | at 2023-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥23.9bn | at 2023-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥22.7bn | at 2024-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥21.7bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥20.1bn | at 2023-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥27.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥27.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥22.9bn | at 2023-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥20.1bn | at 2023-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥2.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥9.0bn | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥2.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥460m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥1.9bn | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥654m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥148m | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥996m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥42.56 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥88.35 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥35.28 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥42.44 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥88.03 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥35.16 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 24.1% | at 2024-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 25.4% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 27.7% | at 2023-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥241m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥241m |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥139m |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥159m |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥22.1bn |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥22.0bn |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥102m |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥305m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥31.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥30.8bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥241m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥218m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥218m |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.0bn |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥122m |
| jpcrp040300-q2r_E05463-000Application Servicereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥86m |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥16.5bn |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥16.4bn |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥95m |
| jpcrp040300-q2r_E05463-000Information Infrastructurereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E05463-000Medical System Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥498m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥24.8bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥24.6bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥218m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥2.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 809
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenue from external customers IFRS | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration | 24602651000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember | 95435000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember | 122104000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember | - | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_ReportableSegmentsMember | 217540000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_ReconcilingItemsMember | -217540000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration | - | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember | 16466310000 | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember | 3995237000 | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember | 4358644000 | JPY |
| Revenue IFRS | Prior1YTDDuration_ReportableSegmentsMember | 24820191000 | JPY |
| Revenue IFRS | Prior1YTDDuration_ReconcilingItemsMember | -217540000 | JPY |
| Revenue IFRS | Prior1YTDDuration | 24602651000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember | 1697243000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember | 86137000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember | 498239000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_ReportableSegmentsMember | 2281620000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 2281620000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 15299000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | 19292000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1YTDDuration | -3413000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 2274212000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember | 22046904000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember | 4385841000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember | 4409058000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_ReportableSegmentsMember | 30841805000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration | 30841805000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember | 101979000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember | 138595000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember | - | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_ReportableSegmentsMember | 240575000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_ReconcilingItemsMember | -240575000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration | - | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember | 22148884000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember | 4524437000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember | 4409058000 | JPY |
| Revenue IFRS | CurrentYTDDuration_ReportableSegmentsMember | 31082380000 | JPY |
| Revenue IFRS | CurrentYTDDuration_ReconcilingItemsMember | -240575000 | JPY |
| Revenue IFRS | CurrentYTDDuration | 30841805000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000InformationInfrastructureReportableSegmentMember | 2559356000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000ApplicationServiceReportableSegmentMember | 159337000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E05463-000MedicalSystemBusinessReportableSegmentMember | 304529000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReportableSegmentsMember | 3023223000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | 3023223000 | JPY |
| Finance income IFRS | CurrentYTDDuration | 83086000 | JPY |
| Finance costs IFRS | CurrentYTDDuration | 35070000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |